When should a drug be pulled from shelves? How do you pronounce “HLTH?” And how does Ann Coulter decide what to tweet?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Ed Silverman joins us to explain the ongoing controversy over a drug meant to prevent premature births that might not actually work. Then, we discuss what happened at HLTH, a Las Vegas conference that united the likes of Mark Cuban and Anne Wojcicki to debate the future of tech in medicine. Later, STAT Washington correspondent Lev Facher calls in to explain an interesting new debate in Congress: How many new drugs does society really need?
For more on what we cover, here’s the story on the premature birth treatment; here’s more from HLTH; and here’s the latest on the drug pricing debate.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
